Using the unique Utah Population Database, which links Utah genealogical data with Utah cancer data, we examined risks for other cancers among relatives of 4,079 melanoma cases. Age- and sex-specific rates for 35 different cancer sites were calculated, and used to estimate relative risks among relatives. In addition to the well-recognized risk for melanoma among first-degree relatives, we found significantly increased risks for prostate, breast, and colon cancers, non-Hodgkin's lymphoma, and multiple myeloma, ranging from 32 to 72% increased risk. Among second-degree relatives, in addition to increased risk for melanoma, we identified significantly increased risks for prostate cancer and multiple myeloma (27 and 53% increase, respectively)....
While it is recognized that relatives of melanoma patients are at increased risk for this disease, t...
Familial cancer risk has been proposed as a shared feature of many cancers, and overall susceptibili...
Background: Malignant Melanoma (MM) is familial in 5-7% of cases. Germline mutations of the CDKN2 an...
A family history of cutaneous melanoma ('melanoma') is a well-established risk factor for melanoma. ...
Using the Swedish Family-Cancer Database, we assessed the effect of a detailed family history of mel...
We evaluated the risk of developing melanoma over time in members of 23 melanoma-prone families. All...
Using the Swedish Family-Cancer Database, we assessed the effect of a detailed family history of mel...
We studied familial risks in invasive and in situ cutaneous melanoma by comparing the occurrence of ...
Background: Malignant melanoma (MM) patients are at increasing risk of developing second primary can...
Background: A family history of melanoma is associated with an increased risk of melanoma and probab...
Background: Malignant melanoma (MM) patients are at increasing risk of developing second primary can...
Objective Melanoma has been shown in numerous studies to be associated with sun exposure, and with h...
The purpose of this study was to quantify the risk of cancers other than melanoma among family membe...
While it is recognized that relatives of melanoma patients are at increased risk for this disease, t...
While it is recognized that relatives of melanoma patients are at increased risk for this disease, t...
While it is recognized that relatives of melanoma patients are at increased risk for this disease, t...
Familial cancer risk has been proposed as a shared feature of many cancers, and overall susceptibili...
Background: Malignant Melanoma (MM) is familial in 5-7% of cases. Germline mutations of the CDKN2 an...
A family history of cutaneous melanoma ('melanoma') is a well-established risk factor for melanoma. ...
Using the Swedish Family-Cancer Database, we assessed the effect of a detailed family history of mel...
We evaluated the risk of developing melanoma over time in members of 23 melanoma-prone families. All...
Using the Swedish Family-Cancer Database, we assessed the effect of a detailed family history of mel...
We studied familial risks in invasive and in situ cutaneous melanoma by comparing the occurrence of ...
Background: Malignant melanoma (MM) patients are at increasing risk of developing second primary can...
Background: A family history of melanoma is associated with an increased risk of melanoma and probab...
Background: Malignant melanoma (MM) patients are at increasing risk of developing second primary can...
Objective Melanoma has been shown in numerous studies to be associated with sun exposure, and with h...
The purpose of this study was to quantify the risk of cancers other than melanoma among family membe...
While it is recognized that relatives of melanoma patients are at increased risk for this disease, t...
While it is recognized that relatives of melanoma patients are at increased risk for this disease, t...
While it is recognized that relatives of melanoma patients are at increased risk for this disease, t...
Familial cancer risk has been proposed as a shared feature of many cancers, and overall susceptibili...
Background: Malignant Melanoma (MM) is familial in 5-7% of cases. Germline mutations of the CDKN2 an...